Future Research Directions and Emerging Applications Systemic Administration and Biodistribution Studies While most clinical applications of GHK-Cu involve topical administration, emerging research explores systemic delivery routes including subcutaneous injection, intravenous infusion, and oral administration for potential applications in systemic inflammation, tissue remodeling, and age-related decline
Treatments are intended to support the bodys natural functions and should be part of a comprehensive health plan supervised by a physician
Common side effects include headache, migraine, irritability, restlessness, joint or muscle discomfort, poor sleep, and low mood
Recent research indicates that neuronal ATP and adenosine interact with their respective receptors-P2X and P2Y for ATP, and adenosine A 2A receptors (A 2A R) for adenosine-leading to pericyte contraction, which reduces CBF, or membrane hyperpolarization, which increases CBF [26, 87,88,89]